GBS Inc. (GBS) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 50 transactions totaling $7.0M, demonstrating a bearish sentiment with -$6.8M in net insider flow. The most recent transaction on Oct 10, 2022 involved a transaction of 75,000 shares valued at $0.
No significant insider buying has been recorded for GBS in the recent period.
No significant insider selling has been recorded for GBS in the recent period.
Based on recent SEC filings, insider sentiment for GBS is bearish with an Insider Alignment Score of 1/100 and a net flow of -$6.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at GBS Inc. (GBS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading GBS stock, having executed 50 transactions in the past 90 days. The most active insider is Science Biosensor Diagnostics Pty Ltd Life (Executive), who has made 32 transactions totaling $6.9M.
Get notified when executives and directors at GBS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 10, 2022 | Kevin Sakiris Spiro | Executive | Award | 75,000 | $N/A | $0 | |
| Oct 10, 2022 | Constantine Boyages Steven | Executive | Award | 75,000 | $N/A | $0 | |
| Oct 10, 2022 | B. Fisher Lawrence | Executive | Award | 15,000 | $N/A | $0 | |
| Oct 10, 2022 | Margelis George | Executive | Award | 15,000 | $N/A | $0 | |
| Oct 10, 2022 | Towers Christopher | Executive | Award | 15,000 | $N/A | $0 | |
| Oct 10, 2022 | Scott Hurd Jonathan | Executive | Award | 15,000 | $N/A | $0 | |
| Oct 10, 2022 | Simeonidis Harry | Executive | Award | 80,000 | $N/A | $0 | |
| Jun 22, 2022 | Kevin Sakiris Spiro | Executive | Purchase | 5,000 | $0.65 | $3.3K | |
| Jun 17, 2022 | Kevin Sakiris Spiro | Executive | Purchase | 15,970 | $0.61 | $9.7K | |
| Feb 17, 2022 | Biosensor Diagnostics Pty Ltd Life Science | Executive | Sale | 576,028 | $0.51 | $293.8K | |
| Feb 16, 2022 | Biosensor Diagnostics Pty Ltd Life Science | Executive | Sale | 100,000 | $0.63 | $63.0K | |
| Feb 15, 2022 | Biosensor Diagnostics Pty Ltd Life Science | Executive | Sale | 100,000 | $0.68 | $68.0K | |
| Feb 14, 2022 | Biosensor Diagnostics Pty Ltd Life Science | Executive | Sale | 100,000 | $0.70 | $70.0K | |
| Feb 11, 2022 | Biosensor Diagnostics Pty Ltd Life Science | Executive | Sale | 100,000 | $0.75 | $75.0K | |
| Feb 10, 2022 | Biosensor Diagnostics Pty Ltd Life Science | Executive | Sale | 100,000 | $0.84 | $84.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 31 | $6.9M | 98.8% |
Purchase(P) | 10 | $85.0K | 1.2% |
Award(A) | 7 | $0 | 0.0% |
Exercise (Options)(X) | 2 | $0 | 0.0% |
Insider selling pressure at GBS Inc. has increased, with 10 insiders executing 50 transactions across all time. Total sales of $6.9M significantly outpace purchases of $85.0K, resulting in a net outflow of $6.8M. This selling activity appears largely discretionary, which may warrant closer attention from investors.